PHR1678

ビカルタミド(CDX)

Pharmaceutical Secondary Standard; Certified Reference Material

• 別名: N-[4-シアノ-3-(トリフルオロメチル)フェニル]-3-[(4-フルオロフェニル)スルホニル]-2-ヒドロキシ-2-メチルプロパンアミド, コスデックス
• 実験式（ヒル表記法）: C₁₈H₁₄F₄N₂O₄S
• CAS番号: 90357-06-5
• 分子量: 430.37
• MDL番号: MFCD00869971
• UNSPSCコード: 41116107
• PubChem Substance ID: 329823550
• NACRES: NA.24

特性

• グレード: certified reference material; pharmaceutical secondary standard
• 品質水準: 300
• 認証: traceable to BP 1115; traceable to Ph. Eur. Y0001444; traceable to USP 1071202
• APIファミリー: bicalutamide
• CofA: current certificate can be downloaded
• 包装: pkg of 1 g
• テクニック: HPLC: suitable; gas chromatography (GC): suitable
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F
• InChI: 1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)
• InChI Key: LKJPYSCBVHEWIU-UHFFFAOYSA-N
• 遺伝子情報: human ... AR(367)

詳細

詳細

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Bicalutamide is a non-steroidal peripheral androgen receptor inhibitor. Its mode of action involves inhibiting androgen by binding to cytosol androgen receptors in the target tissue.

アプリケーション

Bicalutamide may be used as a pharmaceutical reference standard for the determination of the analyte by high performance liquid chromatography and UV spectrophotometry.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

生物化学的／生理学的作用

ビカルタミド(CDX)は非ステロイド性のアンドロゲンレセプターアンタゴニストであり、純粋な抗アンドロゲンです。ヒストンアセチル化/脱アセチル化のバランス調節やコレギュレーターの動員を介して作用します。ビカルタミド(CDX)によりアンドロゲンを介した遺伝子発現が停止します。その例として、前立腺癌におけるMMP13の発現上昇や、PLZF(promyelocytic leukemia zinc finger protein)、GADD45γ(growth arrest and DNA damage inducible, gamma)などがあります。アンドロゲンにより刺激される転写非依存的な非ゲノム性のPI3K/AKTリン酸化もビカルタミド(CDX)によって阻害されます。

アナリシスノート

このような2次標準は、入手可能な場合にはUSP、EP、BPの1次標準にマルチトレーサビリティを提供します。

その他情報

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

脚注

To see an example of a Certificate of Analysis for this material enter LRAA6123 in the slot below. This is an example certificate only and may not be the lot that you receive.

おすすめ製品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

安全性情報

• ピクトグラム: GHS08,GHS09
• シグナルワード: Danger
• 危険有害性情報: H351,H360FD,H410
• 注意書き: P202 - P273 - P280 - P308 + P313 - P391 - P405
• 危険有害性の分類: Aquatic Chronic 1 - Carc. 2 - Repr. 1B
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable